{"id":"W6902175935","doi":"10.6084/m9.figshare.26378046.v1","title":"Additional file 1 of Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 study","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Pembrolizumab; Placebo; Lung cancer; Immunotherapy; Phases of clinical research; PD-L1","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002283262,0.001428154,0.002212466,0.0009184551,0.0008760173,0.001299259,0.0016065,0.001441377,0.8599641],"category_scores_gemma":[0.01962623,0.0008123233,0.001642634,0.001666282,0.0002754816,0.001467489,0.0005679465,0.001282756,0.08421009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001174038,"about_ca_system_score_gemma":0.00205236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00263003,"about_ca_topic_score_gemma":0.005505104,"domain_scores_codex":[0.9990477,0.0003305567,0.0001585751,0.0001780757,0.00015001,0.0001350528],"domain_scores_gemma":[0.9852271,0.01075251,0.001574329,0.0007077737,0.00119234,0.0005459819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03664468,0.00164451,0.001648232,0.01977929,0.0007768495,0.0001120252,0.00007504901,0.001365987,0.0003441367,0.00176509,0.8907899,0.0450543],"study_design_scores_gemma":[0.4245451,0.0111668,0.0259035,0.008812519,0.00262256,0.0007333169,0.0001800617,0.00389204,0.001688577,0.01581818,0.5043996,0.0002376781],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.001021306,0.0002487125,0.0004771985,0.0003206899,0.00009138536,0.002323733,0.992048,0.0003118976,0.003157153],"genre_scores_gemma":[0.06425355,0.001730756,0.01409461,0.0034371,0.0007184357,0.06913707,0.7898221,0.001172443,0.05563399],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.8599641,"threshold_uncertainty_score":0.1997443,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07809445917721287,"score_gpt":0.3548470916386028,"score_spread":0.2767526324613899,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}